Monopar Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-7.3M | $-7.3M | — | — |
| FY2022 | $-7.2M | $-7.2M | — | $1.6M |
| FY2023 | $-7.9M | $-7.9M | — | $1.9M |
| FY2024 | $-6.4M | $-6.4M | — | $1.1M |
| FY2025 | $-12.2M | $-12.2M | — | $4.8M |